CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement of Corbus Pharmaceuticals Holdings, Inc. on Form S-3 to be filed on or about May 31, 2023 of our reports dated March 7, 2023, on our audits of the consolidated financial statements as of December 31, 2022 and 2021 and for each of the years then ended, which report was included in the Annual Report on Form 10-K filed March 7, 2023. We also consent to the reference to our firm under the caption Experts in the Registration Statement on Form S-3.
/s/ EisnerAmper LLP
Iselin, New Jersey
May 31, 2023